1
Yan M#, Gu X#, Wang Y, Cao B*. Effects of Baloxavir Marboxil Plus Neuraminidase Inhibitor vs Neuraminidase Inhibitor in High-risk Patients Hospitalized With Severe Influenza: A Post Hoc Analysis of the Flagstone Trial. Open Forum Infect Dis. 2025 Jul 25;12(8):ofaf439. doi: 10.1093/ofid/ofaf439. PMID: 40852135; PMCID: PMC12368417.
2
Hong L#, Suo L#, Chang K#, Cao H, Luan J, Zhang F, Yu X, Zou X, Liu B*, Cao B*; CAP-China Network. Longitudinal profiling of host response and oropharyngeal respiratory microbiome reveals dynamic alterations during recovery from community-acquired pneumonia. Biosaf Health. 2025 May 15;7(3):152-165. doi: 10.1016/j.bsheal.2025.05.004. PMID: 40693035; PMCID: PMC12276579.
3
Yang X, Lin W, Zhao Y, Zhao C, Zhou F, Wang D, Yue Z, Pei L, Jia M, Cao B, Cao LL, Wang H. Development and validation of a LC-MS/MS method for the simultaneous determination of simnotrelvir and ritonavir in human serum and bronchoalveolar lavage fluid. BMC Chem. 2025 Jul 2;19(1):180. doi: 10.1186/s13065-025-01534-x. PMID: 40605057; PMCID: PMC12224748.
4
Xu JF, Liu Y, Zhang P, Cao B*. From symptom relief to household control: baloxavir redefines antiviral strategies for influenza. Lancet Reg Health West Pac. 2025 Aug 2;61:101651. doi: 10.1016/j.lanwpc.2025.101651. PMID: 40799772; PMCID: PMC12341615.
5
Wang Y#, Shang L#, Wu L#, Wang X#, Ding B, Hu K, He Y, Li G, Zhai J, Hu J, Tian Y, Wang J, Yan L, Liu B, Song G, He Y*, Wang C*, Cao B*. The efficacy and safety of inhaled peptide YKYY017 for COVID-19 patients with mild illness: a phase 2 randomized controlled trial. Nat Commun. 2025 Aug 7;16(1):7272. doi: 10.1038/s41467-025-62214-x. PMID: 40775020; PMCID: PMC12332093.
6
Zou X#, Cao H#, Hong L, Suo L, Wang C, Chang K, Ni Y, Liu B*, Cao B*. Enrichment of Streptococcus oralis in respiratory microbiome enhance innate immunity and protects against influenza infection. Signal Transduct Target Ther. 2025 Aug 27;10(1):272. doi: 10.1038/s41392-025-02365-x. PMID: 40858544; PMCID: PMC12381301.
7
Wang Q#, Zhang Y#, Yao X, Wang C, Chen S, Liu B, Sun L, Zou X*, Cao B*. Distinct microbiome variation in children and adults following RSV infection and its association with host response. Microb Pathog. 2025 Dec;209:108075. doi: 10.1016/j.micpath.2025.108075. Epub 2025 Sep 29. PMID: 41033368.
8
Shang X#, Jia J, Yu J, Zou S, Wang Z, Xu J, Li H*, Cao B*. Monocyte-derived macrophages support alveolar regeneration via oncostatin M post-H1N1 infection during the recovery phase. Respir Res. 2025 Oct 8;26(1):285. doi: 10.1186/s12931-025-03359-7. PMID: 41063200; PMCID: PMC12509380.
9
Xu Y#, Zheng Y#, Liu Y#, Wei C#, Ren J, Zuo W, Gu R, Liu H, Deng X, Liu Y, Shang X, Ge W, Li Z, Huang Y, He D, Shen X, Wang Z, Lyu C, Wang Z, Mu Y, Zhang Z, Wu H*, Li H*, Cao B*. Ninjurin-1 mediates cell lysis and detrimental inflammation of PANoptosis during influenza A virus infection. Signal Transduct Target Ther. 2025 Sep 23;10(1):307. doi: 10.1038/s41392-025-02391-9. PMID: 40983621; PMCID: PMC12454662.
10
Zhang L#, Liu D#, Cao X, Zhang H, Li S, Wang R, Mu Y, Han M, Wang Y, Cao B*. Long-term effectiveness of COVID-19 vaccination in preventing hospitalization among household contacts: A case-control study from December 2021 to April 2023. Hum Vaccin Immunother. 2025 Dec;21(1):2563760. doi: 10.1080/21645515.2025.2563760. Epub 2025 Oct 28. PMID: 41147322; PMCID: PMC12574579.
11
Li J#, Jin Y#, Wang Y, Shang L, Cao B*. New Developments in Influenza Polymerase Inhibitors. J Infect Dis. 2025 Oct 17;232(Supplement_3):S227-S242. doi: 10.1093/infdis/jiaf126. PMID: 41102615.
12
Sherman AC, Gray GE, Cao B, To KKW, Rouphael N, Henao-Restrepo AM, Gordon AC, Baden LR. Acute SARS-CoV-2 infection. Nat Rev Dis Primers. 2025 Oct 24;11(1):75. doi: 10.1038/s41572-025-00662-x. PMID: 41136410.
13
Zhang L#, Shao Y#, Zou X#, Cui Y#, Ding S, Chen Y, Wu Q, Mu S, Li X, Yang Q, Cao B*, Deng T*. A primary oseltamivir-resistant mutation in influenza hemagglutinin and its implications for antiviral resistance surveillance. Nat Commun. 2025 Dec 10;16(1):11442. doi: 10.1038/s41467-025-66307-5. PMID: 41372193; PMCID: PMC12749811.
14
Yao X, Zou X, Cao B*. The Human Respiratory Virome in Health and Disease: Interactions, Dysbiosis, and Methodological Challenges. Adv Genet (Hoboken). 2025 Dec 2;6(4):e00022. doi: 10.1002/ggn2.202500022. PMID: 41473686; PMCID: PMC12747556.
15
Zhang R#, Shang X#, Wang C#, Zhou H, Liu N, Shen X, Wang Z, Xu J, Zhong D, Li H, Cao B*. Rhinovirus-associated lower respiratory tract infection in hospitalized adult patients: a retrospective cohort study. J Infect Dis. 2025 Dec 26:jiaf651. doi: 10.1093/infdis/jiaf651. Epub ahead of print. PMID: 41457011.
16
Jin Y#, Hu Q#, Li J, Liu D, Gu X, Xu J, Liu L, Hu H, Wang W, Wang Y*, Cao B*. Risk factors for severe and prolonged cough in influenza and COVID-19: A post hoc analysis of three randomized controlled trials. Chin Med J Pulm Crit Care Med. 2025 Dec 12;3(4):319-322. doi: 10.1016/j.pccm.2025.11.007. PMID: 41551015; PMCID: PMC12805390.
